(NASDAQ: NDRA) Endra Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 41.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.
Endra Life Sciences's earnings in 2025 is -$9,768,577.On average, 1 Wall Street analyst forecast NDRA's earnings for 2025 to be -$7,627,362, with the lowest NDRA earnings forecast at -$7,627,362, and the highest NDRA earnings forecast at -$7,627,362.
In 2026, NDRA is forecast to generate -$7,383,700 in earnings, with the lowest earnings forecast at -$7,383,700 and the highest earnings forecast at -$7,383,700.